• Home
  • News
2021-12-15 | views:1350
“폐암 NGS 패널 검사, 기적을 만드는 도구입니다
2021-12-10 | views:1592
Bringing NGS-Based Testing Closer to Home: The Need for Wider Access
2021-12-07 | views:2254
The Omicron Variant Highlights the Need for Smarter, Future-Proof Vaccine Design
2021-12-07 | views:2031
Study analyzes the contribution of AI to cancer patient care and vaccine design
2021-11-25 | views:1214
New Study Shows How Ancestry Shapes Our Immune Response
2021-11-18 | views:901
코리컴퍼니, 美 인피니플루딕스와 mRNA 백신 신제조 공법 전략적 파트너십 계약
2021-11-08 | views:1114
바이러스 정복하는 유전자 가위 기술
2021-11-04 | views:1470
First patient treated with novel Cancer Vaccine
2021-11-01 | views:1422
Flu, cancer, HIV: after Covid success, what next for mRNA vaccines?
  1.   
  2. 34
  3. 35
  4. 36
  5. 37
  6. 38
  7. 39
  8. 40
  9.   
  • 10F, 173, Digital-ro, Geumcheon-gu, Seoul (Gasan-dong, Elysian)
  • Tel : 02-890-8700
  • IR Service : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

Private Policy Terms of Use twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.